049180 — Cellumed Co Share Price
0.000.00%
Last trade - 00:00- KR₩52bn
- KR₩53bn
- KR₩129bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 5.98 | ||
| Price to Tang. Book | 6 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.41 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -243.43% | ||
| Return on Equity | -201.97% | ||
| Operating Margin | -22.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | 73,187.7 | 99,917.91 | 122,085.26 | 95,552.96 | 129,139.78 | n/a | n/a | 48.44% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
CELLUMED CO., LTD., formerly Korea Bone Bank CO., LTD, is a Korea-based company engaged in the manufacture and sale of medical equipment and biosimilars. The Company’s products consist of allografts for tissue repair; bone sponges, bone powders and demineralized bone matrixes (DBMs) for bone regeneration; biosimilars, such as bone morphogenetic protein 2 (BMP2) reagents and others, as well as medical devices, such as spinal fixation systems, joint replacements and navigation systems. The Company sells its products within domestic market and to overseas markets.
Directors
- Yeong Bok Shim CEO (57)
- Jeong Seop Park VMG (48)
- Ji Wuk Jung MDR (45)
- Yeong Taek Song OTH (45)
- Ju Wung Jang OTH (44)
- Jun Gu Lee OTH (44)
- Jeong Yeol Kim DRC (58)
- Jae Hun Yoo DRC (49)
- Dae Seok Seo NID (49)
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- April 30th, 1985
- Public Since
- May 23rd, 2002
- No. of Shareholders
- 32,092
- No. of Employees
- 74
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 51,506,898
- Address
- 402, NamsungPlaza, Ace Techno Twr 9-Cha, SEOUL, 08589
- Web
- https://www.cellumed.co.kr/
- Phone
- +82 221040475
- Auditors
- JungjinSerim Accounting Corp.
Upcoming Events for 049180
Q2 2025 Cellumed Co Ltd Earnings Release
Similar to 049180
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
What is the Cellumed Co share price?
As of Today at 19:50 UTC, shares in Cellumed Co are trading at KR₩1,019. This share price information is delayed by 15 minutes.
How has the Cellumed Co share price performed this year?
Shares in Cellumed Co last closed at KR₩1,019 and the price had moved by -41.72% over the past 365 days. In terms of relative price strength the Cellumed Co share price has underperformed the FTSE Developed Asia Pacific Index by -41.06% over the past year.
What are the analyst and broker recommendations for Cellumed Co?
There is no consensus recommendation for this security.
Find out moreWhat is the Cellumed Co dividend yield?
Cellumed Co does not currently pay a dividend.
Does Cellumed Co pay a dividend?
Cellumed Co does not currently pay a dividend.
When does Cellumed Co next pay dividends?
Cellumed Co does not currently pay a dividend.
How do I buy Cellumed Co shares?
To buy shares in Cellumed Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Cellumed Co?
As of the previous close price of KR₩1,019, shares in Cellumed Co had a market capitalisation of KR₩52bn.
Where are Cellumed Co shares listed?
Here are the trading details for Cellumed Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 049180
What kind of share is Cellumed Co?
Based on an overall assessment of its quality, value and momentum Cellumed Co is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Cellumed Co share price forecast for 2025?
We could not find analyst target price data for this security.
Find out moreWhat is the trend in the Cellumed Co share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cellumed Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -61.35%.
As of the last closing price of KR₩1,019, shares in Cellumed Co were trading -50.55% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Cellumed Co PE Ratio?
The Cellumed Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,019.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Cellumed Co?
Cellumed Co's management team is headed by:
- Yeong Bok Shim - CEO
- Jeong Seop Park - VMG
- Ji Wuk Jung - MDR
- Yeong Taek Song - OTH
- Ju Wung Jang - OTH
- Jun Gu Lee - OTH
- Jeong Yeol Kim - DRC
- Jae Hun Yoo - DRC
- Dae Seok Seo - NID